This nationwide registry study from Denmark investigated the impact of socioeconomic factors and growth hormone (GH) treatment on mortality in adults with adult-onset GH deficiency. The study included 276 patients with GH deficiency and 25,717 matched controls. Results indicated that GH-treated patients exhibited reduced all-cause and malignancy-related mortality compared to
